Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor

Korean journal of ophthalmology : KJO

Volumn 29, Issue 4, 2015, Pages 226-232

  Moon, Da Ru Chi ^a   Lee, Dong Kyu ^a   Kim, Soon Hyun ^a   You, Yong Sung ^a   Kwon, Oh Woong ^a  

^a NUNE Eye Hospital   (South Korea)

Author keywords

Aflibercept; Anti vascular endothelial growth factor; Bevacizumab; Macular degeneration; Polypoidal choroidal vasculopathy

Indexed keywords

AFLIBERCEPT; ANGIOGENESIS INHIBITOR; BEVACIZUMAB; HYBRID PROTEIN; RANIBIZUMAB; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANTAGONISTS AND INHIBITORS; CHOROID; CHOROID DISEASES; COMBINATION DRUG THERAPY; COMPLICATION; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINAL NEOVASCULARIZATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VASCULARIZATION; VISUAL ACUITY; WET MACULAR DEGENERATION;

ANGIOGENESIS INHIBITORS; BEVACIZUMAB; CHOROID; CHOROID DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; RANIBIZUMAB; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETINAL NEOVASCULARIZATION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 85012862380     PISSN: None     EISSN: 20929382     Source Type: Journal    
DOI: 10.3341/kjo.2015.29.4.226     Document Type: Article

References (0)